Last edited by Mezile
Thursday, February 6, 2020 | History

3 edition of Context of medicines in developing countries found in the catalog.

Context of medicines in developing countries

studies in pharmaceutical anthropology

by

  • 131 Want to read
  • 23 Currently reading

Published by Kluwer Academic Publishers in Dordrecht, the Netherlands, Boston, Mass .
Written in English

    Places:
  • Developing countries.
    • Subjects:
    • Materia medica -- Developing countries.,
    • Pharmaceutical industry -- Developing countries.,
    • Medical anthropology -- Cross-cultural studies.

    • Edition Notes

      Includes bibliographical references and indexes.

      Statementedited by Sjaak van der Geest and Susan Reynolds Whyte.
      SeriesCulture, illness, and healing ;, v. 12
      ContributionsGeest, Sjaak van der, 1943-, Whyte, Susan Reynolds.
      Classifications
      LC ClassificationsRS153 .C74 1988
      The Physical Object
      Paginationxiii, 393 p. ;
      Number of Pages393
      ID Numbers
      Open LibraryOL2527973M
      ISBN 10155608059X
      LC Control Number88003273

      National and Local Clinical Guidelines In many industrial countries, evidence-based clinical guidelines are used to ensure high-quality care, better health outcomes, and cost-effective treatments. Once ownership of the resource was in the hands of the community, overharvesting ceased. Another lesson is that globalization isn't an equalizing phenomenon. Determine how incentives can be used in biodiversity restoration efforts in degraded systems. The costs of local interventions depend on local prices of such inputs as labor, transportation, training kits, food, space rental, and accommodations.

      Performance-based remuneration has been successfully used in the United States to compensate both private and public providers McBride, Neiman, and Johnson Quality Assessment Perspectives We can look at the Institute of Medicine's aims from two perspectives: patient perception, and technical or professional assessment. Effective disincentives require 1 knowledge of the effects of management activities on the environment, and 2 regulatory and judicial institutions able to design and enforce the disincentive system. Because exactly the same case can be given to many providers, vignettes are useful for comparison studies.

      Venkataswamy, and A. This book is a first attempt to remedy that situation. The direct and indirect costs of interventions at the central or local government level are harder to quantify. This paper provides a call to action to create an evidence base for health professionals in developing countries and identify appropriate strategies for the dissemination of this information in realistic and meaningful ways.


Share this book
You might also like
Beyond a boundary.

Beyond a boundary.

Ancestral voices

Ancestral voices

Non-federal censuses of Florida, 1784-1945

Non-federal censuses of Florida, 1784-1945

Topics in gastroenterology.

Topics in gastroenterology.

History and ideology in ancient Israel

History and ideology in ancient Israel

Christmas Gifts: Matthew 2:11

Christmas Gifts: Matthew 2:11

Vauxhall Cavalier owners workshop manual

Vauxhall Cavalier owners workshop manual

Sabre-tooth

Sabre-tooth

Winget Patchwork Praise Bible Cover Extra Large

Winget Patchwork Praise Bible Cover Extra Large

Aspects of distance learning provision in polytechnics and colleges: business and management studies

Aspects of distance learning provision in polytechnics and colleges: business and management studies

Frontlines

Frontlines

Handbook for members of hospital management committees

Handbook for members of hospital management committees

Context of medicines in developing countries book

The within-country range of quality of doctors was 10 times as great as the between-country range. Are the risks of injury minimal for patients in the health system? Patents are temporary monopolies granted by governments. The number of lives saved depends on the effect of the intervention—that is, the change in the percentage of cases diagnosed and treated; the prevalence rate of both types of pneumonia; the population covered by each provider; the case-fatality ratio; and the effectiveness of the treatment.

Many of the poorest countries have no indigenous capacity to manufacture pharmaceuticals, and thus they will need to import if they are to make use of generic drugs.

From the information marshaled for this chapter, we can draw five conclusions: Better quality leads to better health outcomes in developing countries. Organizations such as the Robert Wood Johnson Foundation, the Nuffield Trust, and the Institute for Healthcare Improvement cultivate ideas for improvement, bring people and organizations together to learn from each other, and take action to achieve results.

Determine whether the value of natural capital increases when it complements man-made capital and vice versa. Bennett, B. It presents studies of the ways Western medicines are circulated and understood in the cities and rural areas of Africa, Asia and Latin America.

It also holds the promise of managing populations rather than individuals by aggregating patients into groups. It is an extremely valuable resource for all in clinical practice, for students of medicine, nursing, pharmacy and related sciences, and also for those in medicines regulation, pharmacovigilance and the pharmaceutical industry.

Apart from offering much-needed basic descriptions especially in developing countriesthese studies can test specific indicators of the dimensions of quality and can compare the measurement approaches discussed earlier.

Our prototype intervention has two cost components: the cost of implementing an educational activity for providers and the cost of treating nonsevere and severe childhood pneumonia.

Policy Interventions to Improve Quality The success of quality improvement policies can be measured by their ability to raise the average level of health and reduce variation in quality. In Haiti, a performance-based payment scheme was set up for NGOs that provided services to the population.

States can be disciplined through the WTO's dispute settlement mechanism. Document how policies and management for macroeconomic objectives can lead to mismanagement of economics based mainly on biological resources, particularly local microeconomies. A relatively new disincentive system involves environmental bondingwherein a company or institution wishing to exploit a natural resource or utilize an environmental service posts a bond.

Vignettes have several other advantages. Examples of this optimal outcome must be actively sought out and reported, because the success of a given investment cannot be known in advance Berwick The benefits of high-volume care persist, however, even after controlling for referral and case-mix biases.

Only if you consider the U. Such studies should be complemented by cost-benefit and cost-effectiveness analyses. The World Development Report, in analysing the risks and opportunities that the global information revolution presents for developing countries, concludes that access to financial, technical and healthcare knowledge is crucial to improving the health and living standards of the poor.

Providers and insurers also benefit from lower costs by avoiding unnecessary or inappropriate care. Injections, capsules and tablets are available in city markets and village shops, from 'traditional' practitioners and street vendors, as well as from more orthodox sources like hospitals.

This undermines the logic of free trade that the WTO is based upon. Our quality-of-care framework supports these findings. More complex procedures, including endarterectomy, cancer surgery, and coronary bypass surgery, have shown similar effects.

These civil servants operate alongside autonomous, self-governed, private providers—independent for-profit physicians and health clinics and nonprofit nongovernmental organizations NGOs.Jan 16,  · Treatment recommendations are consistent with the WHO Essential Medicines programs, the best available evidence from research in developing countries, and require only basic laboratory investigations that are available in most small hospitals (such as full blood examination, blood slide for malarial parasites and CSF microscopy).Cited by: Context of Medicines in Developing Countries Studies in Pharmaceutical Anthropology; Context of Medicines in Developing Countries Studies in Pharmaceutical Anthropology.

by Van der Geest, Sjaak, Whyte, Susan R. by Van der Geest, Sjaak, Whyte, Susan R.

The Context of Medicines in Developing Countries: Studies in Pharmaceutical Anthropology

Recommend this! Marketplace Prices. In the third part of the book, broader perspectives are presented – from a primary-care overview of prescribing for women, through to regulatory, political and religious aspects, including issues in developing countries.

The two final chapters focus on communicating the benefits and. Read "The Context of Medicines in Developing Countries Studies in Pharmaceutical Anthropology" by available from Rakuten Kobo. Western pharmaceuticals are flooding the Third World. Injections, capsules and tablets are available in city markets and Brand: Springer Netherlands.

The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is an international legal agreement between all the member nations of the World Trade Organization (WTO). It sets down minimum standards for the regulation by national governments of many forms of intellectual property (IP) as applied to nationals of other WTO member atlasbowling.com: Annex to the Agreement establishing the World.

The Context of Medicines in Developing Countries

Buy the Hardcover Book The Context of Medicines in Developing Countries: Studies in Pharmaceutical Anthropology by Sjaak van der Geest at atlasbowling.com, Canada's largest bookstore. + .